BioSpace News Archive

Pandion will also directly license multiple lead antibodies from Distributed Bio and may internalise the SuperHuman platform.

The CHMP has provided the Day 195 List of Outstanding Issues (LoOI) to the company with a request for responses during the next available submission window of January 23, 2018.

Ms. Lawton has more than 30 years of experience in a range of executive and operating roles in the biopharmaceutical industry.

KVK Tech today announced the launch of its first mobile app, the LOMAIRA Daily Dose Tracker, available for Android and iOS.

SSI announces the release of its MALDI-8020, marking SSI’s return to benchtop matrix assisted laser desorption ionization time of flight mass spectrometry.

CompactCath today announced its flagship intermittent urinary catheter has received CE Mark approval as a Class III Medical Device.

The results support the use of pathological complete response (pCR) as a primary endpoint for accelerated approval of new drugs.

Tremeau announced today that it has recently gained agreement with the FDA, in a formal Type B Meeting, on the development requirements to support a New Drug Application.

Dec. 12, 2017 13:00 UTC Next-Generation Technology Enables New Commercial Model for Life Sciences Companies DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--( BUSINESS WIRE )-- IQVIA (NYSE:IQV), a company dedicated to using analytics and science to help healthcare stakeholders find better solutions for patients, today announced the launch of a new commercial technology solution, Orchestrated Customer Engag

Contraction and relaxation of smooth muscle cells and fibroblasts within the bronchial airways dramatically affects airflow, and being able to modulate these processes is critical for treating asthma and allergic responses.